WallStSmart
ERNA

Eterna Therapeutics Inc

NASDAQ: ERNA · HEALTHCARE · BIOTECHNOLOGY

$0.15
-21.24% today

Updated 2026-04-30

Market cap
$5.59M
P/E ratio
P/S ratio
1,275.37x
EPS (TTM)
$-2.24
Dividend yield
52W range
$0 – $4
Volume
1.1M

Eterna Therapeutics Inc (ERNA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-604.00M$2.50M$2.83M$574000.00$2.16M$1.49M$-6.38M$-4.18M$23000.00$549000.00$1.36M$2.74M$-8.10M$-23.49M$-20.98M$-20.41M$-15.84M$-7.02M
Capital expenditures$0.00$0.00$0.00$1.91M$1.32M$1.59M$1.23M$861000.00$835000.00$1.63M$840000.00$1.45M$1.61M$1.09M$39000.00$154000.00$297000.00$19000.00$369000.00$37000.00
Depreciation$3.93B$3.19M$3.20M$3.26M$2.88M$2.85M$2.75M$3.10M$2.89M$2.32M$2.76M$3.17M$98000.00$459000.00$497000.00$1.12M$1.64M
Stock-based comp$490.00M$180000.00$299000.00$332000.00$185000.00$132000.00$282000.00$456000.00$419000.00$457000.00$443000.00$206000.00$91000.00$5.24M$2.94M$1.24M$1.52M$1.50M
Free cash flow$-604.00M$593000.00$1.51M$-1.02M$930000.00$632000.00$-7.22M$-5.81M$-817000.00$-903000.00$-247000.00$1.65M$-8.14M$-23.64M$-21.27M$-20.43M$-16.20M$-7.05M
Investing cash flow$-1.62M$-840000.00$-1.45M$-1.58M$-1.06M$-39000.00$-22.74M$-47000.00$-19000.00$-365000.00
Financing cash flow$9000.00$-24000.00$623000.00$-364000.00$-300000.00$1.95M$3.75M$10.08M$1.98M$3.26M$-1.47M$-303000.00$-1.10M$4.67M$61.59M$19.58M$16.56M$6.26M
Dividends paid$16000.00$16000.00$16000.00$16000.00$16000.00$16000.00$16000.00$16000.00$8000.00$16000.00$16000.00$16000.00
Share repurchases
Debt repayment
Net change in cash